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Abstract 
With the obesity epidemic, and the effects of aging populations, human phenotypes have 
changed over two generations, possibly more dramatically than in other species previously. 
As obesity is an important and growing hazard for population health, we recommend a 
systematic evaluation of the optimal measure(s) for population-level excess body fat. Ideal 
measure(s) for monitoring body composition and obesity should be simple, as accurate and 
sensitive as possible, and provide good categorisation of related health risks. Combinations of 
anthropometric markers or predictive equations may facilitate better use of anthropometric 
data than single measures to estimate body composition for populations. Here we provide 
new evidence that increasing proportions of aging populations are at high health-risk 
according to waist circumference, but not body mass index (BMI), so continued use of BMI 
as the principal population-level measure substantially underestimates the health-burden from 
excess adiposity.    
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Background to the problem 
Obesity has been defined as a disease, with an International Classification of Diseases code, 
since the 1940s, but its prevalence and the complexity of its health consequences have 
changed radically since that time.  The World Health Organization (WHO) defines obesity in 
two ways: first, “abnormal or excessive fat accumulation that may impair health”, secondly, 
the most commonly used in epidemiology (assuming Europids), “a body mass index (BMI) 
greater than or equal to 30 kg/m
2”. While weight and height can be measured cheaply and 
accurately, measuring body fat is more problematic as there is no ‘gold-standard’ reference 
method.  Imaging, such as Magnetic Resonance Imaging, can measure adipose tissue volume 
accurately, but adipose tissue comprises only about 80% of total body fat, on average. That 
proportion varies substantially with obesity, with age and between sexes.  Two-component 
methods, such as underwater weighing or deuterium dilution reliably estimate total body fat, 
but are too expensive and time-consuming for population-level use.  Derivative methods such 
as Dual-energy X-ray absorptiometry, or bioelectrical impedance analysis (BIA), calibrated 
against one of the reference methods, are still too cumbersome for large-scale surveys.  
Anthropometric measures provide simpler, less expensive, assessment of body composition, 
and they may have similar accuracy to methods such as BIA although direct comparisons 
have not been published.   
 
Which anthropometric measure(s) best identify high-risk adiposity has been much debated.  
While height and weight are easily measured, variations in the resulting BMI do not 
distinguish between differences in fat mass and muscle mass, factors which have opposite 
impacts on health and well-being, so BMI has poor discriminatory power. BMI explains 
about 67-75% of variance in Total Body Fat 
1
 (more so in women than in men) and its 
sensitivity to identify excess adiposity has been estimated at around 50%.
2
 Its applicability in 
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certain sub- populations can be misleading. For example, many athletes have large muscle-
masses, resulting in a high BMI, but with low body fat.  For the same BMI, Europids 
generally have less body fat than Asians, but more than Africans or Pacific Islanders. 
Furthermore, as people age, fat mass tends to increase while muscle mass decreases. Thus 
BMI may be artificially stable despite an increase in body fat, particularly among the elderly. 
The prevalence of sarcopenic obesity (co-existing obesity and sarcopenia, with multiple 
adverse health effects) is estimated to increase 5-fold between ages 60-69 and 80+ years.
3
 
 
This paper does not set out to provide an in-depth review of the methods used to assess body 
composition, but assesses current and emerging options and also includes some new analyses 
of international survey data.  Based on this new data, it draws attention to the limitations of 
BMI in the current context, and proposes alternatives. 
 
Moving on 
Various alternative or additional measures have been advocated to improve estimates of 
adiposity and/or to provide better prediction of ill-health and risk of chronic diseases. These 
include waist circumference (WC), waist-hip ratio (WHR), waist-height ratio, neck 
circumference, conicity index, and body adiposity index.  Most of these involve computation 
of convenience-ratios, which do not correspond to biological interpretation.  They are also 
hard to visualise, a particular obstacle to public understanding in applications for health 
promotion. Where the range of body fat is very large (as in most population surveys), WC 
correlates surprisingly strongly with total body fat, explaining 70.4-77.8% of variance, so it is 
a little better than BMI, at least in men.
1
 It is also a slightly better predictor of metabolic risk 
and chronic diseases than BMI, partly by better identifying  individuals at increased health 
risk through greater total body fat, and partly by also including those with central adiposity 
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who are not identified by BMI.
4
  WC alone has often proved a better correlate of the 
metabolically-hazardous abdominal visceral fat mass than WHR.
5
   
 
Although WHO published a standard method using bony landmarks to measure WC in 1998,
6
 
its value has been devalued by wide use of less reliable methods.  A systematic review of 120 
studies identified 8 different protocols for measuring WC, only three using a site defined by 
fixed skeletal  landmarks: (i) immediately above the iliac crest; (ii) immediately below the 
lowest rib; and (iii) midway between the lowest rib and the iliac crest.
7
  These provide almost 
identical measures, and there is sufficient evidence that, with the appropriate training, WC 
can be measured reliably.
8, 9
 Despite its limitations, WC still predicts health outcomes at least 
as well as BMI.
10, 11  
 
WC was primarily presented as an indicator for health promotion, with ‘Action Levels’ 
defined from regression curves against BMI and WHR among Europid adults.
4
  These cut-
points (Supplementary material, Table 1) have now been extensively validated by 
epidemiological research and were adopted by WHO and International Diabetes Federation in 
their recommendations for high-risk adiposity and associated health risks for Europid adults. 
Associations between risk factors and diseases are continuous, without discrete thresholds 
separating disease and no-disease, but cut-points are valuable for population health 
monitoring, to classify and quantify likely disease burdens, and to target health promotion. 
Although a large body of literature agrees that WC (and indices which include WC) predict 
metabolic outcomes a little more strongly than BMI, and most surveys now include WC, BMI 
has remained the primary measure for policy. Measurements of height, weight, and derived 
BMI in clinical practice had the highest inter-observer reliability (r>0.99) compared to other 
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anthropometric measures for adiposity, though improvements have been observed for the 
other measures after training sessions.
9
  
 
Changing needs in changing landscapes 
As populations grow more obese and live longer, shapes have changed radically and 
improved population-level surveillance is critical to inform and adjust policies and priorities, 
to monitor secular changes with age and over time, and to assess the impact of interventions. 
In defining classification cut-offs, the ability to identify individuals at high risk (sensitivity) is 
important, without misclassifying too many at lower risk (specificity).  However, using single 
outcomes (e.g. cardiovascular risk) to define specificity cut-offs, or in receiver operating 
characteristic (ROC) analysis, can be misleading.  The commonest outcomes related to body 
composition considered in population surveys are type 2 diabetes, hypertension, heart disease 
and cancers.  It has become customary to use area under the ROC curve statistics to balance 
specificity and sensitivity of cut-points, but it is most important to recognise that for 
adiposity, sensitivity and specificity are not equally important, because the intervention 
(weight management and prioritisation of prevention) has multiple benefits and minimal 
detriments.   
 
As outlined above, there are clearly many reasons to challenge the WHO statement that “BMI 
provides the most useful population-level measure of overweight and obesity”. New analyses 
of international data mean that it is now time to move beyond BMI. These data suggest that, 
by using BMI alone, large and increasing segments of the burden of preventable ill-health 
related to adverse adiposity go unrecognised (Figure 1, grey shading).
12, 13
 According to an 
Australian study in 2000, approximately 40% of the adults with a high-risk WC would not 
have been identified as high-risk because they had a non-obese BMI.
12
  Similarly, the 
 
 
7 
 
Scottish Health Surveys and Health Surveys for England 2008-2010, found that 39% of 
adults with a high-risk WC were non-obese by BMI.
13
 In both cases, approximately 18% of 
individuals in the general population who are at increased health risk through excess 
adiposity would not be identifiable using BMI. In American adults (NHANES 1999–2000), a 
high-risk WC  was present in 8%  of participants with a normal BMI, 43% of those with BMI 
25-30 kg/m
2
, and 96% of participants with BMI >30 kg/m
2
.
14
  This serious discordance 
between WC and BMI has grown more marked over recent years. WC has increased at a 
greater rate than BMI in those populations where it has been measured, and in some 
populations has continued to increase despite an apparent plateau in BMI (Supplementary 
material, Table 2).
15-19
 Older people may even lose weight while continuing to increase 
WC.
20
   
 
Actions and Solutions  
All the data discussed above indicate that as modern populations live to greater ages, 
preventable ill-health associated with excess adiposity will continue to increase, but BMI 
alone will not serve health planners well (Figure 2). Public health researchers and politicians 
cannot be complacent about the obesity epidemic if rising BMI appears to level off.   
 
The question we must ask is: who and what are we missing under current monitoring 
approaches?  BMI (alone) is not an ideal indicator for the health burden associated with 
adverse body compositions given that the determinants of preventable health risks are in fact 
body fatness and muscle mass, operating on BMI in opposite directions and varying 
independently.
21
  BMI and WC coupled together may predict health outcomes better, as is 
beginning to be recognized by clinical guidelines. Large numbers with low-to-moderate BMI  
despite a large WC will be misclassified into the normal-adiposity group. In an analysis of 
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over 200,000 people in 17 countries, a higher WC was associated with a greater risk of 
cardiovascular disease even in those low (<24.5 kg/m
2
) and middle third (24.5-<28.0 kg/m
2
) 
of the BMI distribution. 
22
 There is some suggestion of a similar relationship with mortality in 
men.
23
 Using prediction equations or categorical combinations of anthropometric markers 
would additionally reduce problems related to measurement errors. A recent systematic 
review found that combining crude indicators of body fat and gluteal muscle, waist and hip 
circumferences (but not as a fixed ratio) improved risk prediction models for cardiovascular 
disease and other outcomes.
24
 Importantly, the authors acknowledged that their findings did 
not dispute the contribution of adiposity to cardiovascular risk, since excess adiposity 
influences blood pressure, diabetes and lipids, and that in settings where information of lipids 
is not available, substitution with anthropometric indicators for adiposity results in only 
modest lost of predictive ability.  
 
It is now also possible to use published, and externally validated, equations based on standard 
measurements made in populations surveys (age, sex, height, weight, waist, hips) to capture 
variations in fat and muscle masses separately.
25
 As with BMI or WC alone, individual 
categorisation should be avoided, but trends within populations, over time and with age, in 
body fat and skeletal muscle masses can provide much more specific information, potentially 
guiding future health promotion better than has been possible hitherto. 
 
In conclusion, population health surveillance still focuses heavily on BMI alone, 
consequently missing almost a half of the population who are at increased health risk through 
excess adiposity. It is time to improve guidelines for population monitoring approaches by 
using other (combinations of) measures for body composition and to estimate both excess 
adiposity and low skeletal muscle mass, whose combined influences are lost with BMI. The 
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optimal measure(s) should take into consideration measurement feasibility and accuracy, as 
well as strength, sensitivity and positive and negative predictive values for key health 
outcomes. Improved identification at a population level of those at increased health risk 
would lead to better prioritisation of policy and resources.  
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FIGURES 
 
Figure 1. Identification of different individuals with high risk adiposity using body mass 
index (≥30 kg/m2) or waist circumference (≥102 cm for men, ≥88 cm for women) in: (A) the 
combined Scottish Health Survey (SHS)/Health Survey for England (HSE) data from the UK; 
and (B) the Australian AusDiab study.
(15, 16)
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Figure 2. Prevalence by age of elevated WC (>80 cm for women, >94 cm for men) among 
individuals with BMI within the range 18.5–25 kg/m2 in 2008-10 (data for Scotland and 
England combined)
(29)
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Supplementary material 
Table 1. Waist Circumference Cut-offs for Health Promotion and Risk Classification 
(6, 9)
  
Classification Risk of co-morbidities
a
 
Caucasian 
Risk of co-morbidities 
Asian 
 BMI 
(kg/m
2
) 
Waist circumference (cm) BMI 
(kg/m
2
) 
Waist circumference (cm) 
  Men 94-102  
Women 80-
88
b
  
Men >102  
Women >88
c
  
 Men < 90  
Women < 80  
Men ≥ 90  
Women ≥ 80  
Normal 
weight 
18.5 – 24.9 – – d 18.5 – 22.9 Average Increased 
Overweight 25.0 – 29.9 Increased High 23.0 – 24.9 Increased Moderate 
Obese  
Class I 
Class II 
Class III 
 
30.0 – 34.9 
35.0 – 39.9 
≥ 40.0 
 
High 
Very high 
Extremely 
high 
 
Very high 
Very high 
Extremely 
high 
 
25.0 – 29.9 
≥ 30.0 
 
Moderate 
Severe 
 
Severe 
Very severe 
a
 Disease risk for type 2 diabetes, hypertension, and cardiovascular disease 
b
 Action level 1: for individuals to take personal steps to control weight/waist gain 
c
 Action level 2:  professional input is required to achieve sustained weight/waist loss 
d
 Increased waist circumference can also be a marker for increased risk even in persons of normal weight 
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Table 2. Studies Examining Changes in BMI and Waist Circumference   
Country  Year Findings 
United States 
(22)
 1988 – 1994 to 
2005 – 2006  
Waist circumference has increased more than BMI (on 
average by 0.86 cm)  
Scotland 
(20)
 1998 – 2008 Proportionally greater increases in WC than in BMI. 
Finland 
(19)
 1987 – 2002 Increases in BMI had slowed in men and remained 
stable in women. Increases in abdominal obesity had 
continued in both sexes. 
Hong Kong 
(18)
 1996 – 2005  In men, the prevalence of general obesity (BMI ≥25 
kg/m
2
) remained stable but the prevalence of central 
obesity (waist circumference ≥90 cm) increased 
between 1996 and 2005. In the women, the prevalence 
of general obesity declined while the prevalence of 
central obesity (waist circumference ≥80 cm) remained 
stable. 
Australia 
(21)
 2000 – 2005 
(period 1) and 
2005 – 2012 
(period 2) 
The annualized weight gain in period 2 was 
0.11kg/year less than in period 1, while the annualized 
waist circumference increase in period 2 was 
0.07cm/year greater than in period 1. 
 
 
